Global Tumor Multigene Detection Kit Market Growth 2024-2030

Publication ID:

LPI08246293

Publication Date:

August 21, 2024

Pages:

121

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Tumor NGS detection kit is an experimental consumable used in tumor detection
The global Tumor Multigene Detection Kit market size is projected to grow from US$ 857.9 million in 2023 to US$ 2513.5 million in 2030; it is expected to grow at a CAGR of 16.6% from 2024 to 2030.
The 鈥淭umor Multigene Detection Kit Industry Forecast鈥� looks at past sales and reviews total world Tumor Multigene Detection Kit sales in 2023, providing a comprehensive analysis by region and market sector of projected Tumor Multigene Detection Kit sales for 2024 through 2030. With Tumor Multigene Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Multigene Detection Kit industry.
This Insight Report provides a comprehensive analysis of the global Tumor Multigene Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Multigene Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Tumor Multigene Detection Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Multigene Detection Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Multigene Detection Kit.
United States market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Tumor Multigene Detection Kit players cover Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific and Memorial Sloan Kettering, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Multigene Detection Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
Segmentation by application
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Foundation Medicine
Illumina Inc.
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
NantHealth
Personal Genome Diagnostics
GTH.O
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tumor Multigene Detection Kit market?
What factors are driving Tumor Multigene Detection Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tumor Multigene Detection Kit market opportunities vary by end market size?
How does Tumor Multigene Detection Kit break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tumor Multigene Detection Kit Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tumor Multigene Detection Kit by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tumor Multigene Detection Kit by Country/Region, 2019, 2023 & 2030
2.2 Tumor Multigene Detection Kit Segment by Type
2.2.1 Reversible End Termination Sequencing
2.2.2 Semiconductor Sequencing
2.2.3 Combined Probe Anchored Polymerization Sequencing
2.3 Tumor Multigene Detection Kit Sales by Type
2.3.1 Global Tumor Multigene Detection Kit Sales Market Share by Type (2019-2024)
2.3.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Type (2019-2024)
2.3.3 Global Tumor Multigene Detection Kit Sale Price by Type (2019-2024)
2.4 Tumor Multigene Detection Kit Segment by Application
2.4.1 Companion Diagnostics
2.4.2 Early Cancer Screening
2.4.3 Drug Discovery
2.4.4 Other
2.5 Tumor Multigene Detection Kit Sales by Application
2.5.1 Global Tumor Multigene Detection Kit Sale Market Share by Application (2019-2024)
2.5.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Application (2019-2024)
2.5.3 Global Tumor Multigene Detection Kit Sale Price by Application (2019-2024)
3 Global Tumor Multigene Detection Kit by Company
3.1 Global Tumor Multigene Detection Kit Breakdown Data by Company
3.1.1 Global Tumor Multigene Detection Kit Annual Sales by Company (2019-2024)
3.1.2 Global Tumor Multigene Detection Kit Sales Market Share by Company (2019-2024)
3.2 Global Tumor Multigene Detection Kit Annual Revenue by Company (2019-2024)
3.2.1 Global Tumor Multigene Detection Kit Revenue by Company (2019-2024)
3.2.2 Global Tumor Multigene Detection Kit Revenue Market Share by Company (2019-2024)
3.3 Global Tumor Multigene Detection Kit Sale Price by Company
3.4 Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Multigene Detection Kit Product Location Distribution
3.4.2 Players Tumor Multigene Detection Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tumor Multigene Detection Kit by Geographic Region
4.1 World Historic Tumor Multigene Detection Kit Market Size by Geographic Region (2019-2024)
4.1.1 Global Tumor Multigene Detection Kit Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Tumor Multigene Detection Kit Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Tumor Multigene Detection Kit Market Size by Country/Region (2019-2024)
4.2.1 Global Tumor Multigene Detection Kit Annual Sales by Country/Region (2019-2024)
4.2.2 Global Tumor Multigene Detection Kit Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tumor Multigene Detection Kit Sales Growth
4.4 APAC Tumor Multigene Detection Kit Sales Growth
4.5 Europe Tumor Multigene Detection Kit Sales Growth
4.6 Middle East & Africa Tumor Multigene Detection Kit Sales Growth
5 Americas
5.1 Americas Tumor Multigene Detection Kit Sales by Country
5.1.1 Americas Tumor Multigene Detection Kit Sales by Country (2019-2024)
5.1.2 Americas Tumor Multigene Detection Kit Revenue by Country (2019-2024)
5.2 Americas Tumor Multigene Detection Kit Sales by Type
5.3 Americas Tumor Multigene Detection Kit Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Multigene Detection Kit Sales by Region
6.1.1 APAC Tumor Multigene Detection Kit Sales by Region (2019-2024)
6.1.2 APAC Tumor Multigene Detection Kit Revenue by Region (2019-2024)
6.2 APAC Tumor Multigene Detection Kit Sales by Type
6.3 APAC Tumor Multigene Detection Kit Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tumor Multigene Detection Kit by Country
7.1.1 Europe Tumor Multigene Detection Kit Sales by Country (2019-2024)
7.1.2 Europe Tumor Multigene Detection Kit Revenue by Country (2019-2024)
7.2 Europe Tumor Multigene Detection Kit Sales by Type
7.3 Europe Tumor Multigene Detection Kit Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tumor Multigene Detection Kit by Country
8.1.1 Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2019-2024)
8.1.2 Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2019-2024)
8.2 Middle East & Africa Tumor Multigene Detection Kit Sales by Type
8.3 Middle East & Africa Tumor Multigene Detection Kit Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit
10.3 Manufacturing Process Analysis of Tumor Multigene Detection Kit
10.4 Industry Chain Structure of Tumor Multigene Detection Kit
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Multigene Detection Kit Distributors
11.3 Tumor Multigene Detection Kit Customer
12 World Forecast Review for Tumor Multigene Detection Kit by Geographic Region
12.1 Global Tumor Multigene Detection Kit Market Size Forecast by Region
12.1.1 Global Tumor Multigene Detection Kit Forecast by Region (2025-2030)
12.1.2 Global Tumor Multigene Detection Kit Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tumor Multigene Detection Kit Forecast by Type
12.7 Global Tumor Multigene Detection Kit Forecast by Application
13 Key Players Analysis
13.1 Roche Foundation Medicine
13.1.1 Roche Foundation Medicine Company Information
13.1.2 Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Foundation Medicine Main Business Overview
13.1.5 Roche Foundation Medicine Latest Developments
13.2 Illumina Inc.
13.2.1 Illumina Inc. Company Information
13.2.2 Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
13.2.3 Illumina Inc. Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Illumina Inc. Main Business Overview
13.2.5 Illumina Inc. Latest Developments
13.3 Life Technologies Corporation
13.3.1 Life Technologies Corporation Company Information
13.3.2 Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
13.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Life Technologies Corporation Main Business Overview
13.3.5 Life Technologies Corporation Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Memorial Sloan Kettering
13.5.1 Memorial Sloan Kettering Company Information
13.5.2 Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
13.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Memorial Sloan Kettering Main Business Overview
13.5.5 Memorial Sloan Kettering Latest Developments
13.6 Novogene
13.6.1 Novogene Company Information
13.6.2 Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
13.6.3 Novogene Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Novogene Main Business Overview
13.6.5 Novogene Latest Developments
13.7 Geneseeq
13.7.1 Geneseeq Company Information
13.7.2 Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
13.7.3 Geneseeq Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Geneseeq Main Business Overview
13.7.5 Geneseeq Latest Developments
13.8 AmoyDx
13.8.1 AmoyDx Company Information
13.8.2 AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
13.8.3 AmoyDx Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AmoyDx Main Business Overview
13.8.5 AmoyDx Latest Developments
13.9 Burning Rock Medicine
13.9.1 Burning Rock Medicine Company Information
13.9.2 Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Burning Rock Medicine Main Business Overview
13.9.5 Burning Rock Medicine Latest Developments
13.10 NantHealth
13.10.1 NantHealth Company Information
13.10.2 NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
13.10.3 NantHealth Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 NantHealth Main Business Overview
13.10.5 NantHealth Latest Developments
13.11 Personal Genome Diagnostics
13.11.1 Personal Genome Diagnostics Company Information
13.11.2 Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
13.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Personal Genome Diagnostics Main Business Overview
13.11.5 Personal Genome Diagnostics Latest Developments
13.12 GTH.O
13.12.1 GTH.O Company Information
13.12.2 GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
13.12.3 GTH.O Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 GTH.O Main Business Overview
13.12.5 GTH.O Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂